| 1 |
汪忠镐, 吴继敏, 胡志伟, 等. 中国胃食管反流病多学科诊疗共识 [J/OL]. 中华胃食管反流病电子杂志, 2020, 7(1): 1-28.
|
| 2 |
中国医师协会外科医师分会胃食管反流病专业委员会. 成人胃食管反流病外科诊疗共识(2025版) [J/OL]. 中华胃食管反流病电子杂志, 2025, 12(1): 1-9.
|
| 3 |
周金池, 窦维佳, 魏延, 等. 中国胃食管反流病患者焦虑抑郁患病率的Meta分析 [J]. 中国全科医学, 2021, 24(5): 608-613.
|
| 4 |
李修业, 方向明. 胃食管反流病影响因素及相关机制研究进展 [J]. 胃肠病学和肝病学杂志, 2025, 34(3): 420-423.
|
| 5 |
Wang J, Song M, Cao M. The causal role of multiple psycho-emotional disorders in gastroesophageal reflux disease: a two-sample Mendelian randomized study [J]. PLoS One, 2024, 19(5): e0302469.
|
| 6 |
Zheng X, Zhou X, Tong L, et al. Mendelian randomization study of gastroeso phageal reflux disease and major depression [J]. PLoS One, 2023, 18(9): e0291086.
|
| 7 |
黎丽群, 谭金晶, 刘园园, 等. 基于"菌群-肠-脑轴"探讨"以枢调枢"治疗GERD共病抑郁症的生物学基础 [J]. 中国中西医结合消化杂志, 2025, 33(3): 281-286.
|
| 8 |
Zamani M, Alizadeh-Tabari S, Chan WW, et al. Association between anxiety/depression and gastroesophageal reflux: a systematic review and meta-analysis [J]. Am J Gastroenterol, 2023, 118(12): 2133-2143.
|
| 9 |
You ZH, Perng CL, Hu LY, et al. Risk of psychiatric disorders following gastroesophageal reflux disease: a nationwide population-based cohort study [J]. Eur J Intern Med, 2015, 26(7): 534-539.
|
| 10 |
里提甫江·买买提艾力, 买买提·依斯热依力, 阿巴伯克力·乌斯曼, 等. 焦虑、抑郁及睡眠障碍与胃食管反流病的相关研究 [J/OL]. 中华胃食管反流病电子杂志, 2020, 7(4): 202-206.
|
| 11 |
窦维佳, 王新, 胡博, 等. 胃食管反流病与睡眠障碍相关性的临床研究 [J]. 医学研究杂志, 2020, 49(8): 154-157.
|
| 12 |
Gohari A, Baumann B, Jen R, et al. Sleep deficiency: epidemiology and effects [J]. Sleep Med Clin, 2024, 19(4): 509-518.
|
| 13 |
苏雪梅, 孙银平. 老年胃食管反流病患者夜间反流与睡眠障碍的关系分析 [J]. 中国现代医生, 2020, 58(14): 46-48.
|
| 14 |
Ma Y, Yu S, Li Q, et al. Sleep patterns, genetic susceptibility, and digestive diseases: a large-scale longitudinal cohort study [J]. Int J Surg, 2024, 110(9): 5471-5482.
|
| 15 |
赛甫丁·艾比布拉, 买买提·依斯热依力, 王永康, 等. 莫沙必利通过调节5-羟色胺代谢途径改善心理应激诱发食管炎症的作用[J/OL]. 中华胃食管反流病电子杂志, 2023, 10(1): 31-37.
|
| 16 |
He M, Wang Q, Yao D, et al. Association between psychosocial disorders and gastroesophageal reflux disease: a systematic review and meta-analysis [J]. J Neurogastroenterol Motil, 2022, 28(2): 212-221.
|
| 17 |
王永康, 买买提·依斯热依力, 克力木·阿不都热依木. 不同细胞因子与胃食管反流病的研究进展 [J/OL]. 中华胃食管反流病电子杂志, 2023, 10(4): 207-211.
|
| 18 |
陈立柱, 刘嘉. 胃食管反流病相关检验项目及诊断研究 [J]. 中国医学装备, 2019, 16(2): 135-139.
|
| 19 |
Góralczyk-Bińkowska A, Szmajda-Krygier D, Kozłowska E. The microbiota-gut-brain axis in psychiatric disorders [J]. Int J Mol Sci, 2022, 23(19): 11245.
|
| 20 |
Taft TH, Triggs JR, Carlson DA, et al. Validation of the oesophageal hypervigilance and anxiety scale for chronic oesophageal disease [J]. Aliment Pharmacol Ther, 2018, 47(9): 1270-1277.
|
| 21 |
魏秀秀, 张北华, 马祥雪, 等. 肠道菌群与胃食管反流病的相关性研究进展 [J]. 世界中医药, 2024, 19(24): 3903-3908.
|
| 22 |
Aljeradat B, Kumar D, Abdulmuizz S, et al. Neuromodulation and the gut-brain axis: therapeutic mechanisms and implications for gastrointestinal and neurological disorders [J]. Pathophysiology, 2024, 31(2): 244-268.
|
| 23 |
Tait C, Sayuk GS. The brain-gut-microbiotal axis: a framework for understanding functional GI illness and their therapeutic interventions [J]. Eur J Intern Med, 2021, 84: 1-9.
|
| 24 |
Drossman DA. Functional gastrointestinal disorders: history, pathophysiology, clinical features and rome IV [J]. Gastroenterology, 2016: S0016-5085(16)00223-7. Online ahead of print.
|
| 25 |
Longo S, Rizza S, Federici M. Microbiota-gut-brain axis: relationships among the vagus nerve, gut microbiota, obesity, and diabetes [J]. Acta Diabetol, 2023, 60(8): 1007-1017.
|
| 26 |
涂严平. 基于脑肠肽探讨胃食管反流病的发病机制 [J]. 大众科技, 2022, 24(12): 114-118.
|
| 27 |
丁文京. 小肠细菌过度生长和胃食管反流病 [J/OL]. 中华胃食管反流病电子杂志, 2020, 7(3): 182-187.
|
| 28 |
Hoshino M, Omura N, Yano F, et al. The evaluation of recumbent reflux by multichannel intraluminal impedance pH testing for patients with gastroesophageal reflux disease and sleep disturbance [J]. Esophagus, 2020, 17(3): 348-354.
|
| 29 |
Yamasaki T, Quan SF, Fass R. The effect of sleep deficiency on esophageal acid exposure of healthy controls and patients with gastroesophageal reflux disease [J]. Neurogastroenterol Motil, 2019, 31(12): e13705.
|
| 30 |
Besedovsky L, Lange T, Haack M. The sleep-immune crosstalk in health and disease [J]. Physiol Rev, 2019, 99(3): 1325-1380.
|
| 31 |
李友堂, 苏霞, 罗马长, 等. 阻塞性睡眠呼吸暂停综合征并胃食管反流病的分析及研究 [J]. 世界睡眠医学杂志, 2019, 6(10): 1455-1456.
|
| 32 |
El Hage Chehade N, Fu Y, Ghoneim S, et al. Association between obstructive sleep apnea and gastroesophageal reflux disease: a systematic review and meta-analysis [J]. J Gastroenterol Hepatol, 2023, 38(8): 1244-1251.
|
| 33 |
席筱厚, 张明鑫, 林强, 等. 胃食管反流病的诊疗进展 [J]. 胃肠病学和肝病学杂志, 2025, 34(2): 297-302.
|
| 34 |
Yoo IK, Ko WJ, Kim HS, et al. Anti-reflux mucosectomy using a cap-assisted endoscopic mucosal resection method for refractory gastroesophageal disease: a prospective feasibility study [J]. Surg Endosc, 2020, 34(3): 1124-1131.
|
| 35 |
Sumi K, Inoue H, Kobayashi Y, et al. Endoscopic treatment of proton pump inhibitor-refractory gastroesophageal reflux disease with anti-reflux mucosectomy: experience of 109 cases [J]. Dig Endosc, 2021, 33(3): 347-354.
|
| 36 |
Paul S, Abbas MS, Nassar ST, et al. Correlation of anxiety and depression to the development of gastroesophageal disease in the younger population [J]. Cureus, 2022, 14(12): e32712.
|
| 37 |
Caldart F, Gabriel C, Vauquelin B, et al. Overlap of esophageal disorders of gut-brain interactions and gastroesophageal reflux disease is highly prevalent in patients with refractory reflux symptoms [J]. Am J Gastroenterol, 2025, 120(8): 1770-1778.
|
| 38 |
Broers C, Geeraerts A, Boecxstaens V, et al. The role of serotonin in the control of esophageal sensitivity assessed by multimodal stimulation in health [J]. Neuro Gastro Enterol Motil, 2021, 33(3): e14057.
|
| 39 |
Saleh S, Fass R. The use of antidepressants in patients with depression is associated with gastroesophageal reflux disease and disease severity [J]. Neuro gastroenterol Motil, 2025, 37(6): e70010.
|
| 40 |
董若木, 刚宸, 李宏旭, 等. 伴有焦虑抑郁的胃食管反流病的药物研究进展 [J]. 中国医药生物技术, 2024, 19(1): 62-65.
|
| 41 |
Wołowiec Ł, Osiak-Gwiazdowska J, Jaśniak A, et al. Pharmacodynamics, pharmacokinetics, interactions with other drugs, toxicity and clinical effectiveness of proton pump inhibitors [J]. Front Pharmacol, 2025, 16: 1507812.
|
| 42 |
Akiyama J, Kuribayashi S, Baeg MK, et al. Current and future perspectives in the management of gastroesophageal reflux disease [J]. Ann N Y Acad Sci, 2018, 1434(1): 70-83.
|